MétaCan
Menu
Back to cohort
Record W3004129727 · doi:10.1002/jor.24616

Adjuvant antibiotic‐loaded bone cement: Concerns with current use and research to make it work

2020· article· en· W3004129727 on OpenAlexaff
Edward M. Schwarz, A. C. McLaren, Thomas P. Sculco, Barry D. Brause, Mathias P. Bostrom, Stephen L. Kates, Javad Parvizi, Volker Alt, William V. Arnold, Alberto Carli, Antonia F. Chen, Hyonmin Choe, Débora C. Coraça‐Huber, Michael B. Cross, Michelle Ghert, Noreen J. Hickok, Jessica Amber Jennings, Manjari Joshi, Willem‐Jan Metsemakers, Mark Ninomiya, Kohei Nishitani, Irvin Oh, Douglas E. Padgett, Benjamin F. Ricciardi, Kordo Saeed, Parham Sendi, Bryan D. Springer, Paul Stoodley, Joseph C. Wenke

Bibliographic record

VenueJournal of Orthopaedic Research® · 2020
Typearticle
Languageen
FieldMedicine
TopicOrthopedic Infections and Treatments
Canadian institutionsMcMaster University
FundersNational Institute of General Medical SciencesNational Biofilms Innovation CentreNational Institute of Arthritis and Musculoskeletal and Skin DiseasesBiotechnology and Biological Sciences Research CouncilStavros Niarchos FoundationHospital for Special Surgery
KeywordsBone cementAntibioticsAdjuvantDosingDrug deliveryIntensive care medicineMedicineMaterials scienceMicrobiologyCementPharmacologyNanotechnologyImmunologyBiology

Abstract

fetched live from OpenAlex

Antibiotic-loaded bone cement (ALBC) is broadly used to treat orthopaedic infections based on the rationale that high-dose local delivery is essential to eradicate biofilm-associated bacteria. However, ALBC formulations are empirically based on drug susceptibility from routine laboratory testing, which is known to have limited clinical relevance for biofilms. There are also dosing concerns with nonstandardized, surgeon-directed, hand-mixed formulations, which have unknown release kinetics. On the basis of our knowledge of in vivo biofilms, pathogen virulence, safety issues with nonstandardized ALBC formulations, and questions about the cost-effectiveness of ALBC, there is a need to evaluate the evidence for this clinical practice. To this end, thought leaders in the field of musculoskeletal infection (MSKI) met on 1 August 2019 to review and debate published and anecdotal information, which highlighted four major concerns about current ALBC use: (a) substantial lack of level 1 evidence to demonstrate efficacy; (b) ALBC formulations become subtherapeutic following early release, which risks induction of antibiotic resistance, and exacerbated infection from microbial colonization of the carrier; (c) the absence of standardized formulation protocols, and Food and Drug Administration-approved high-dose ALBC products to use following resection in MSKI treatment; and (d) absence of a validated assay to determine the minimum biofilm eradication concentration to predict ALBC efficacy against patient specific micro-organisms. Here, we describe these concerns in detail, and propose areas in need of research.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.443
Threshold uncertainty score0.790

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0030.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.002
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.236
GPT teacher head0.436
Teacher spread0.200 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations151
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Orthopaedic Research®Same topicOrthopedic Infections and TreatmentsFrench-language works237,207